Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Research & Development (2019 - 2025)

Outset Medical (OM) has disclosed Research & Development for 7 consecutive years, with $5.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Research & Development changed N/A to $5.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $36.1 million, a N/A change, with the full-year FY2025 number at $21.2 million, down 44.7% from a year prior.
  • Research & Development was $5.4 million for Q3 2025 at Outset Medical, down from $5.5 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $16.1 million in Q3 2023 to a low of $5.4 million in Q3 2025.
  • A 5-year average of $11.1 million and a median of $11.4 million in 2022 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: surged 68.34% in 2022, then crashed 56.35% in 2025.
  • Outset Medical's Research & Development stood at $11.4 million in 2021, then rose by 0.3% to $11.4 million in 2022, then rose by 9.51% to $12.5 million in 2023, then grew by 0.82% to $12.6 million in 2024, then plummeted by 57.45% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Research & Development are $5.4 million (Q3 2025), $5.5 million (Q1 2025), and $12.6 million (Q1 2024).